The stock is still 25% off all-time highs.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Abbott Laboratories (NYSE:ABT) reported second-quarter 2026 comparable sales growth of 4.8% and adjusted earnings per share of $1.31, with Chairman and Chief Executive Officer Robert Ford saying results marked an acceleration from the prior two quarters. The company reaffirmed its full-year compara
STT posts Q2 earnings beat as record revenues, AUC/A and AUM, higher NII and fee income, and no credit-loss provision lift results.
Interactive Brokers' Q2 results may reflect the benefits of higher client trading, rising accounts and stronger net interest income.
Capital One's Q2 earnings are likely to have gained from card loans, NII and fee income, while higher provisions and expenses are expected to have put pressure.

Insurance giant UnitedHealth Group (UNH) is out with its second quarter earnings on Thursday, raising its full-year outlook alongside its reported $112 billion in quarterly revenue. The stock has jumped in Thursday trading. Mizuho Americas healthcare equity strategist Jared Holz takes a closer look at the insurer's stock performance and the role Medicare Advantage had in its figures.
Taiwan Semiconductor Manufacturing Co (ADR) (NYSE:TSM) posted a 77% jump in second-quarter net profit and raised its capital spending forecast for the year, as the world's largest contract chipmaker rides sustained demand for AI processors. Net profit came in at $22.36 billion for the...
United Airlines Holdings Inc (NASDAQ:UAL, XETRA:UAL1) shares fell about 2% after the carrier issued third quarter earnings guidance below Wall Street expectations, despite reporting second quarter results that topped analyst estimates and raising its full-year adjusted earnings outlook. For...
AVB heads into Q2 with strong occupancy and firmer leasing as U.S. apartment demand outpaces supply, but rising interest costs remain a headwind.
VICR heads into Q2 earnings with raised revenue guidance, strong AI and licensing demand, and record backlog, but premium valuation raises the stakes.
TSMC raised its 2026 revenue growth guidance above 40% and lifted capital spending on strong AI chip demand.
Will higher purchase volumes and a wider net interest margin help SYF top Q2 estimates? See the key factors shaping its July 21 earnings report.
Abbott Laboratories (ABT) lifted its full-year earnings outlook on Thursday as the healthcare firm r
Aehr Test Systems reported past fiscal fourth-quarter 2026 results with revenue of US$18.84 million and net income of US$1.39 million, while full-year 2026 sales were US$50.00 million with a net loss of US$7.13 million. The company entered fiscal 2027 with record quarterly bookings of US$60.70 million, an effective backlog above US$80 million, and issued revenue guidance of US$130 million to US$150 million driven by AI processors, silicon photonics, and power semiconductors. Next, we’ll...
In recent days, ON Semiconductor Corp. reported that analysts expect a meaningful uplift in upcoming quarterly earnings per share and revenue, even as the stock lagged a rising broader market. At the same time, Heartland Advisors highlighted ON Semiconductor’s strength in power management and image sensing for electric vehicles and AI datacenters, as well as its ongoing push toward higher-margin products and more efficient manufacturing. Next, we’ll explore how optimism around upcoming...
UnitedHealth Group (NYSE:UNH) reported sharply higher second-quarter 2026 earnings and raised its full-year outlook, citing improved performance in Medicare Advantage and Optum Health, while cautioning that commercial medical cost trends remain elevated and are delaying margin recovery in that busin
Comcast (CMCSA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Teck Resources (TECK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
T-Mobile (TMUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nasdaq (NDAQ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mobileye (MBLY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Primis Financial (FRST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
West Pharmaceutical (WST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
RTX (RTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Roper Technologies (ROP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Sallie Mae (SLM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Norfolk Southern (NSC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Newmont (NEM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Honeywell International (HON) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.